Agilent Simple reversed-phase purification of human Erythropoietin (EPO) from fully formulated drugs

Update: 30 September, 2023

This document describes a method for purifying human erythropoietin (EPO) from formulated drugs using reversed-phase chromatography. This method allows EPO to be purified to homogeneity for further analysis by peptide mapping, mass spectrometry and protein sequencing.


File format: PDF

Size: -

MD5 Checksum: EE295CCCB3F31D35EB85E1B0156E0855

Publication date: 03 July, 2012

Downloads: -

PDF Link: Agilent Simple reversed-phase purification of human Erythropoietin (EPO) from fully formulated drugs PDF

Also Manuals